11 Best Penny Stocks with the Highest Upside Potential

Page 7 of 10

4. AbCellera Biologics Inc. (NASDAQ:ABCL)

Price: $4.65

Number of Hedge Fund Holders: 17

Analyst Upside Potential: 82.80%

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the Best Penny Stocks to Buy with the Highest Upside Potential. Wall Street is bullish on AbCellera Biologics Inc. (NASDAQ:ABCL) since the company released its fiscal second-quarter results for 2025.

The company announced several key clinical announcements, for instance, it started dosing in a Phase 1 trial of ABCL635, aimed at treating moderate-to-severe vasomotor symptoms. Moreover, the company also began a Phase 1 trial for ABCL575 for moderate-to-severe atopic dermatitis. The drug targets the OX40 ligand to regulate inflammation and is engineered for dosing every six months.

In addition, AbCellera Biologics Inc. (NASDAQ:ABCL) also topped analyst expectations with revenue of $17.08 million, which grew 133.29% year-over-year and topped estimates by $10.72 million. Although the company posted a net loss of $0.12 per share, this was ahead of the expectations by $0.04.

Several analysts have reiterated their bullish sentiment since the release. On August 14, Truist Financials reiterated a Buy rating on the stock, with a price target of $10. More recently, on September 11, Brendan Smith from TD Cowen also reiterated a Buy rating on the stock without disclosing any price targets.

AbCellera Biologics Inc. (NASDAQ:ABCL) discovers and develops antibody medicines for various diseases, including cancer, metabolic, endocrine, and autoimmune disorders.

Page 7 of 10